NewULife is suing a former affiliate for more than $100,000, claiming she spread lies about the company's human growth hormone gel product in private messages to other distributors.

Georgia Hargett signed up as a NewULife affiliate about fifteen months ago. Within a year, court documents show, she was telling fellow salespeople the company was run by "crooks and manipulators" who "lie and are deceptive."

But NewULife's real concern isn't her general complaints. It's what Hargett said about Somaderm, the company's flagship product—a gel marketed to boost human growth hormone levels. In messages to affiliate Kim O'Brien, Hargett allegedly claimed the gel was dangerous. When discussing a woman who died of cancer, Hargett told another distributor named Bob Walters that the victim "was a gel user." When Walters asked what caused her lung cancer, Hargett responded: "she was a gel user."

NewULife claims this language—linking the product to the woman's death—amounts to defamation.

Hargett's concerns went deeper. She questioned whether NewULife's leadership even understood basic chemistry. In a message to affiliate Carolyn Stone, Hargett claimed that someone named Alex at the company admitted the gel's "inactive ingredients ARE active." She wrote that these powerful ingredients were "causing the hormonal shifts and bleeding" that women reported experiencing.

The messages paint a picture of a distributor growing alarmed about customer complaints. Hargett eventually quit. In her resignation letter, she said that as a naturopath and company leader, roughly 100 people had approached her "with stories of serious health concerns." She noted a pattern: many complaints came from women experiencing hormonal problems.

"I am not saying that Somaderm hgh gel was the cause of these issue," Hargett wrote. But she couldn't in good conscience keep promoting it.

NewULife frames Hargett's private messages as deliberate lies designed to damage the company. The lawsuit seeks over $100,000 in damages. The company doesn't explain why it had access to Hargett's private chats with other affiliates or what prompted it to sue over year-old conversations.

The case highlights tensions within multi-level marketing operations, where distributors who lose faith in a product face pressure—legal or otherwise—when they speak up. Hargett's messages were never posted publicly. They were sent in confidence to other salespeople. Yet NewULife treated them as actionable defamation worth fighting in court.

🤖 Quick Answer

What is NewULife's lawsuit against former affiliate Georgia Hargett about?
NewULife is suing Georgia Hargett for over $100,000, alleging she made defamatory claims about the company's human growth hormone gel product Somaderm in private messages to other distributors, including statements linking the product to cancer deaths and characterizing company leadership as deceptive.

Who is Georgia Hargett and what was her role at NewULife?
Georgia Hargett was a NewULife affiliate who joined approximately fifteen months before the lawsuit. Within one year, she began making negative statements about company management and the Somaderm product to fellow salespeople and distributors.

What specific claims did Hargett make about Somaderm?
Hargett allegedly told other distributors that Somaderm gel was dangerous and linked it to cancer deaths, specifically claiming a deceased

🔗 Related Articles

- Brent Willis settles NewAge fraud with SEC for $175,000
- Ad Wealth System Review: $25 “unlimited” Ponzi ROIs
- $361 million in WCM777 victim claims disallowed
- $18.2 mill suspended judgment in FTC’s RengaLife case (updates)
- Eddy Alexandre’s initial court appearance and what’s next